Our GI interest group had great representation at #ACG2022
✅6️⃣residents
✅13 posters
✅ 2 presidential poster awards ‼️💙Thanks to our mentors for the support!
@CreightonGi
A New Screening Test that Uses DNA to Detect Esophageal Cancer has been Designated by the FDA as a Breakthrough Device - the First Such Designation for a Device Targeting Diseases of the Esophagus. ECAN spoke with the co-inventor of the Device.
https://t.co/X4O52tFGYF
@LucidDiag
Oral 34 Cumulative Increase in the Prevalence of Esophageal Cancer in Patients With Gastroesophageal Reflux Disease (GERD) and Multiple Risk Factors https://t.co/59LRvszUQV
Oral 34 Cumulative Increase in the Prevalence of Esophageal Cancer in Patients With Gastroesophageal Reflux Disease (GERD) and Multiple Risk Factors https://t.co/59LRvszUQV